Pariser, David, Jeffrey Sussman, Brian Martin, Lindsay Ackerman, Craig Kraffert, and Abel Jarell. “Real-World Evidence Confirms Risk Stratification of the 31-GEP and i31-GEP in Prospectively Tested Patients With Stage I-III Cutaneous Melanoma ”. SKIN The Journal of Cutaneous Medicine 8, no. 2 (March 18, 2024): s386. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/2596.